Psilera is creating next-generation medicines for hard-to-treat psychological disorders.
Psilera
At A
Glance
-
We have created and developed six separate serotonergic compound families.
-
Two patents have been issued from the USPTO covering over 1 million novel compounds. Several more patents expected by 1H 2024.
-
The Psilera leadership team has over 100 years of combined experience in the biotech and pharmaceutical industries.
-
Our best-in-class proprietary compound library has coverage for over 1 million novel compounds.
-
Psilera’s co-founders bring over $1.5B in cumulative value created from prior start-ups.
Psilera is revolutionizing how small molecule drug discovery is done, giving rise to more patient-centric therapy options for those suffering from neurological conditions.
Based on the current pipeline, our focus is on hard-to-treat disorders, many of which have no currently available treatments, such as Frontotemporal Dementia (FTD).
UPCOMING EVENTS
UPCOMING EVENTS
April 18 - 19
San Francisco, CA
Discovery Sessions
Co-Founder Jackie von Salm, PhD will be speaking on both days of this year’s Discovery Sessions gathering in San Francisco, CA. Thursday’s talk, Featured Session: Initiatives in Novel Chemistry, will feature fellow thought leaders Matthew Baggott, PhD, Andrew Bartynski and moderator Matias Serebrinsky. Friday’s panel discussion, Unlocking Addiction: Exploring the Latest Psychedelic Research, Science, and Therapeutic Initiatives, she, Danielle Nova, and Lindsay P. Cameron, PhD will delve into the groundbreaking therapeutic advancements being made with psychedelics in the field of addiction.
May 15 - 16
Miami Beach, FL
The Summit on Breakthrough Therapies for Addiction
Co-Founder and CSO Jackie von Salm, PhD will be attending The Summit on Breakthrough Therapies for Addiction. This pioneering conference in Miami Beach is a nexus point for individuals in all aspects of the addiction treatment field and aims to showcase the transformative potential of cutting-edge research and treatment protocols.
West of Tampa, FL
May 30 - June 1
FAME: ACS Florida Section
Director of Medicinal Chemistry, Elena Bray, PhD, and Director of Drug Discovery & Development, Jeanine Yacoub, MS will be attending the American Chemical Society’s Florida Section FAME Conference. This annual event held at the beautiful Innisbrook Resort gives chemists from across the Sunshine State the ability to share their latest discoveries.
June 3 - 6
San Diego, CA
BIO International
Co-Founders Chris Witowski, PhD and Jackie von Salm, PhD will be in San Diego for the 2024 BIO International Conference. Psilera will be giving a presentation during the event to highlight the latest data from our lead clinical compound: PSIL-006. If you would like to connect with our founders at the event please contact info@psilera.com to arrange a time.